Leveraging NYSCF’s unique automation technology, researchers created neurons from the stem cells of PTSD-affected and non-affected combat veterans and exposed them to synthetic hormones mimicking the body’s stress response. This study, published in Nature Neuroscience, is the first to create a stem cell model of PTSD, showing unique features of hypersensitive PTSD-prone neurons to stress.
A new platform developed by NYSCF scientists integrates robotic systems with artificial intelligence to identify cellular features of disease. A collaborative study with Google Research, published in Nature Communications, examined more than 6 million images to successfully identify new hallmarks of Parkinson’s cells in comparison to healthy controls.
Neurons created from the stem cells of 53 deceased individuals representing the spectrum of brain aging from healthy to Alzheimer’s show the same hallmarks as the actual brain tissue from these individuals, finds a collaborative study in Neuron. This shows that these cells can be used to gain insights into how the brain ages in different people.
The designation and grant from the New York City Economic Development Corporation supports equipment at the NYSCF Research Institute that will scale up studies and drug discovery efforts into diseases such as Alzheimer’s, diabetes, cancer, and more.
The digital program, hosted by Sanjay Gupta, MD, and directed by Scott Ellis, featured numerous celebrity guests and honored 2020 Stem Cell Heroes Frank Gehry, David Rockwell, and Brooke Ellison, PhD.
The meeting featured live video poster presentations, video and chat interactions with the stem cell community, and a keynote by Carl June, MD, of the University of Pennsylvania.
A study published in Neuron led by Valentina Fossati, PhD, shows that astrocytes – an integral support cell in the brain – created from human stem cells can turn into neuron-killers, opening the door for new understanding and treatment of neurodegenerative diseases.
To ensure stem cell education continues during the COVID-19 pandemic, NYSCF launched a new online platform for individuals of all ages. To date, this platform has reached over 3,000 people in 50 different countries.
NYSCF Research Institute scientists and members of the NYSCF Innovator community immediately began developing solutions for those impacted by COVID-19, from better diagnosing the viral infection, to developing treatments and vaccines, to protecting healthcare workers on the front lines.
NYSCF CEO Susan L. Solomon received the 2020 Public Service Award from the International Society for Stem Cell Research (ISSCR) for her outstanding contributions to the field.
A new collaboration between the NYSCF Research Institute, Johns Hopkins University School of Medicine, and Bloomberg Philanthropies will advance precision medicine by combining clinical and medical expertise with NYSCF’s unique stem cell technologies.
Cell Stem Cell published a four-year study of over 500 research institutions using the NYSCF Report Card on Gender Equality, showing a continuing widespread gender imbalance in science, technology, engineering and medicine fields.
NYSCF collaboration launches the first 3D models of Parkinson’s disease and multiple sclerosis to the International Space Station on SpaceX cargo flight CRS-18.
NYSCF is taking on the challenge of these under-researched cancers with our new Women’s Reproductive Cancers Initiative, launched with a discussion and a world-leading Scientific Advisory Board.
NYSCF researchers report in Stem Cell Research that bone-forming cells can be grown without use of animal-derived compounds, paving the way for use in the clinic.
Segmental Additive Tissue Engineering, or SATE, described in Scientific Reports, will allow researchers to create large scale, personalized grafts for those suffering from bone disease or injury.
NYSCF’s inaugural Family Stem Cell Day provided local students with the opportunity to speak with researchers and ask questions about stem cells, NYSCF’s work, and what it’s like to be a scientist.
Inaugural NYSCF – Robertson Stem Cell Prize Recipient Dr. Peter Coffey, DPhil, and collaborators are in clinical trials now treating patients with macular degeneration.
Dedicated the Stavros Niarchos Foundation Scientific Gallery at NYSCF headquarters in Manhattan.
Refined a technique to turn skin cells from patients with mild cognitive impairment into the brain cells that degenerate first in Alzheimer’s disease in collaboration with researchers at the Icahn School of Medicine at Mount Sinai. Reported in Acta Neuropathologica Communications.
A robust, efficient method for deriving microglia, the immune cells of the brain, from human stem cells published in Stem Cell Reports.
Relocates to its expanded laboratories and offices on the far west side of Manhattan.
Creation of a new type of stem cell with only one set of chromosomes, haploid stem cells, with colleagues at The Hebrew University of Jerusalem and Columbia University Medical Center reported in Nature.
Dr. Feng Zhang receives the 6th NYSCF – Robertson Stem Cell Prize for his groundbreaking work pioneering the CRISPR-Cas9 gene editing system.
The NYSCF Global Stem Cell Array highlighted as a faster, more efficient, more reliable, and cost effective method of creating stem cells and derived cell types in Nature Methods.
First meeting of the Immunoengineering Working Group convened to identifying new ways of addressing the immune attack in type 1 diabetes.
NYSCF IWISE Working Group publishes “Seven Actionable Strategies for Advancing Women in Science, Engineering, and Medicine,” in Cell Stem Cell.
Development of a faster protocol to create the cells affected in MS published in Stem Cell Reports.
NYSCF partners with eagle-i Network, of the Harvard Catalyst, creating first-ever open access, searchable stem cell database.
Successful generation of a stem cell model for familial Alzheimer’s disease and identification of fourteen genes that may be implicated in the disease reported in PLOS One.
For the first time, scientists successfully derive living iPS cells from frozen Alzheimer’s patient’s brain tissue, reported in Acta Neuropathologica Communications.
16 leading women in science and technological fields gather for the inaugural meeting of NYSCF’s Initiative for Women in Science and Engineering (IWISE).
Creation of patient-specific, customizable bone to treat disease and injury published in PNAS.
NYSCF is named a “Best Non Profit to Work For” by The Non Profit Times.
Major breakthrough published in Nature describing a therapy that could prevent the inheritance of mitochondrial diseases.
Susan L. Solomon announces The NYSCF Global Stem Cell Array at TED Global in Edinburgh, Scotland.
Awards the NYSCF – Robertson Stem Cell Prize to Dr. Kazutoshi Takahashi for his role in the discovery of induced pluripotent stem cells, a breakthrough that garnered the Nobel Prize for research leader, Dr. Shinya Yamanaka.
Launches Science and Technology Education Program (STEP).
Advance in patient-specific stem cells led named the #1 Medical Breakthrough of 77011 by TIME magazine.
Awards inaugural NYSCF – Robertson Prize to Dr. Peter J. Coffey for use of hESCs to treat a major cause of blindness.
Expands research team to begin research in Alzheimer’s disease, bone regeneration, and multiple sclerosis.
Engineering and building begins on the NYSCF Global Stem Cell Array robotic technology for stem cell production and derivation.
Creates NYSCF – Robertson Investigator program for young scientists starting their own laboratories.
NYSCF Laboratory becomes official New York shared facility under NYSTEM.
Expands research team to begin research in somatic cell nuclear transfer (SCNT) for diabetes.
Susan L. Solomon honored with Women of Excellence Award by Governor David Paterson.
Names first full class of postdoctoral fellows.
Awards first grants for senior scientists.
Advises Gov. Eliot Spitzer and Lt. Gov. David Paterson in drafting NYSTEM, New York State’s 11-year, $600 million stem cell research funding initiative.
Awards first postdoctoral fellowship.
Opens first privately funded “safe haven” stem cell laboratory in New York, free from restrictions tied to federal funding.
Mayor Bloomberg and Dick Wolf speak at NYSCF’s First Annual Gala for scientists and supporters.
Convenes the inaugural Translational Stem Cell Research Conference at The Rockefeller University.
Receives $1.1M of seed funding from two funders.
Susan L. Solomon and Mary Elizabeth Bunzel form The New York Stem Cell Foundation in New York City.
